Evidence map›Paper›PMID 37382831›Full record

ArticleMetabolic brain disease2023

Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice.

Shangwen Jing, Xinyue Wang, Zerong Zhang, Dandan Cao, Kongli Huang, Yuting Wang, Zhuangzhuang Liu, Shijie Su, Qi Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Dihydropashanone Isolated fromInternational journal of molecular sciences · 2024
    Article
  11. Sirtuins as Players in the Signal Transduction ofInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shangwen JingScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0009-0000-4613-2584
Xinyue WangThe Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong, Guangzhou, China.ORCID 0009-0008-8960-0075
Zerong ZhangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0009-0003-6652-7534
Dandan CaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0009-0003-9705-133X
Kongli HuangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0009-0005-6346-4501
Yuting WangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0009-0007-7743-4308
Zhuangzhuang LiuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0009-0005-2165-4913
Shijie SuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangdong, Guangzhou, China.ORCID 0000-0002-3980-1564
Qi WangMedical College of Acupuncture Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China. wangqi@gzucm.edu.cn.ORCID 0000-0001-7626-676X
Guangzhou University of Chinese Medicine · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroinflammation is a critical feature in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD). Hesperetin can exert anti-inflammatory, antioxidant and other neuroprotective effects. In this study, the scopolamine (SCOP)-induced cognitive dysfunction in mice model was used to evaluate the neuroprotective effects of hesperetin. Behavioral tests (Morris water maze, open field, and novel object recognition tests) were conducted to evaluate the effect of hesperetin on cognitive dysfunction behaviors. Nissl staining and Immunofluorescence were used to evaluate hippocampal neuronal damage and microglial activation in mice. The levels of proinflammatory factors, oxidant stress, and the cholinergic neurotransmitter were detected by real-time quantitative fluorescence PCR (RT-qPCR) or biochemical reagent kits. Western blotting was used to detect the relative protein expression of the sirtuin 6 (SIRT6) / NOD-like receptor thermal protein domain associated protein 3 (NLRP3) pathway. Results showed that hesperetin could ameliorate SCOP-induced cognitive impairment and neuronal damage, and regulate the levels of cholinergic neurotransmitters in the hippocampal of AD mice. Hesperetin could also enhance antioxidant defense by regulating the levels of reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT). Hesperetin exerted anti-neuroinflammation effects through inhibiting of microglia activation and down-regulating the mRNA transcript levels of inflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). Meanwhile, hesperetin could attenuate the expression of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), thioredoxin-interacting protein (TXNIP), and caspase-1 p20 and upregulate the expression of SIRT6 in SCOP-induced mice. Overall, our study suggested that hesperetin might ameliorate SCOP-induced cognitive dysfunction by improving cholinergic system dysfunction and suppressing oxidative stress and attenuating neuroinflammation via SIRT6/NLRP3 pathway in mice.

Indexed as

Cognitive DysfunctionNeuroprotective AgentsSirtuinsAnimalsAntioxidantsHesperidinInflammasomesMiceNLR Family, Pyrin Domain-Containing 3 ProteinScopolamineAntioxidantshesperetinHesperidinInflammasomesNeuroprotective AgentsNLR Family, Pyrin Domain-Containing 3 ProteinScopolamineSirtuinsCholinergic systemCognitive impairmentHesperetinNeuroinflammationNLRP3Oxidative stressSIRT6

Identifiers

PMID37382831
OpenAlexW4382502062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.